Trial Profile
Allogeneic,Unrelated, Menstrual Derived, Mesenchymal Stem Cell-Like, Endometrial Cells; Administered Intramuscular
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 01 Jun 2020
Price :
$35
*
At a glance
- Drugs ERC 124 (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral vascular disorders
- Focus Adverse reactions
- Sponsors Medistem
- 12 Jun 2014 New trial record